Sandoz’ Symjepi Set To Undercut Rivals

 
• By Aidan Fry
  
Anaphylaxis
Competition in the US anaphylaxis market is poised to increase with Sandoz' launch of Symjepi • Source: Shutterstock

More from Drug Pricing

More from Policy & Regulation